Inflammatory disease: assault on the guardian.
Ransohoff
Richard M
RM
D000818:Animals; D017209:Apoptosis; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology* / Q000378:metabolism / Q000473:pathology* / Q000517:prevention & control; D006801:Humans; D007249:Inflammation / Q000276:immunology / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control; D020935:MAP Kinase Signaling System; D051379:Mice; D009103:Multiple Sclerosis / Q000276:immunology* / Q000378:metabolism / Q000517:prevention & control*; D009186:Myelin Sheath / Q000276:immunology / Q000473:pathology; D016328:NF-kappa B / Q000378:metabolism; D009457:Neuroglia / Q000473:pathology; D018696:Neuroprotective Agents / Q000276:immunology / Q000378:metabolism* / Q000627:therapeutic use; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology / Q000378:metabolism; D038203:alpha-Crystallin B Chain / Q000235:genetics / Q000276:immunology* / Q000378:metabolism* / Q000627:therapeutic use
D016328:NF-kappa B; D018696:Neuroprotective Agents; D038203:alpha-Crystallin B Chain